Back to MNPR

Candriam S.C.A. → MNPR

Candriam S.C.A. MNPR Position History

Monopar Therapeutics Inc. • Healthcare

Quarters held
2
Latest value
$10.4M
Q3 2026
Peak value
$13.3M
First seen
Q2 2026

Dollar value over time

Show data table
PeriodPosition value
Q2 2026$13.3M
Q3 2026$10.4M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$10.4M129.8K——
Q2 2026$13.3M143.3K——

Other funds holding MNPR

Other Candriam S.C.A. positions

NVDA

NVIDIA CORPORATION

$1.6B
NVDA

NVIDIA CORPORATION

$1.4B
MSFT

MICROSOFT CORP

$1.3B
MSFT

MICROSOFT CORP

$1.3B
NVDA

NVIDIA CORPORATION

$1.3B
NVDA

NVIDIA CORPORATION

$1.3B
NVDA

NVIDIA CORPORATION

$1.3B
MSFT

MICROSOFT CORP

$1.3B